Left atrial appendage closure: patient, device and post-procedure drug selection

Area of Science:

• Cardiology
• Medical Devices
• Interventional Cardiology

Background:

• Atrial fibrillation increases stroke risk, necessitating preventative therapies.
• Oral anticoagulation is standard but carries bleeding risks, especially in certain patient groups.
• Left atrial appendage closure (LAAC) provides a device-based alternative for stroke prevention.

Purpose of the Study:

• To review the current landscape of LAAC devices and procedures.
• To highlight the technical aspects and considerations for successful LAAC.
• To discuss post-procedure antithrombotic strategies.

Main Methods:

• Review of existing clinical trials (e.g., PROTECT AF, PREVAIL) evaluating LAAC devices.
• Description of the transseptal puncture technique under imaging guidance.
• Discussion of device types, including WATCHMAN, WATCHMAN FLX, AMPLATZER Cardiac Plug, and AMPLATZER Amulet.

Main Results:

• LAAC devices have demonstrated proof of concept as effective stroke prevention alternatives.
• The WATCHMAN device showed favorable outcomes compared to warfarin in key trials.
• Successful LAAC depends on careful technique, imaging, and device selection.

Conclusions:

• LAAC is a viable stroke prevention strategy for atrial fibrillation patients, especially those with high bleeding risk.
• Technical proficiency and appropriate device selection are crucial for procedural success.
• Individualized post-procedure antithrombotic management is essential.